Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically (Q84899245)

From Wikidata
Jump to navigation Jump to search
scientific article published on 02 September 2011
edit
Language Label Description Also known as
English
Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically
scientific article published on 02 September 2011

    Statements

    title
    Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21895936
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895936%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    12 February 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q84899245&oldid=1738818694"